JON B. ROUSSEAU - 26 Jan 2024 Form 3 Insider Report for BrightSpring Health Services, Inc. (BTSG)

Role
Officer, Director
Signature
/s/ Steven S. Reed, as Attorney-in-Fact
Issuer symbol
BTSG
Transactions as of
26 Jan 2024
Transactions value $
$0
Form type
3
Filing time
29 Jan 2024, 16:30:06 UTC
Previous filing
30 Jan 2024
Next filing
15 Mar 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding BTSG Common Stock 1.95K 26 Jan 2024 Direct
holding BTSG Common Stock 351K 26 Jan 2024 By Rousseau Family Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding BTSG Stock Options (Right to Buy) 26 Jan 2024 Common Stock 1.33M $6.37 Direct F1
holding BTSG Stock Options (Right to Buy) 26 Jan 2024 Common Stock 535K $6.37 By The Margaret Rousseau Children Trust F2
holding BTSG Stock Options (Right to Buy) 26 Jan 2024 Common Stock 378K $6.37 By Rousseau Family Trust F2
holding BTSG Stock Options (Right to Buy) 26 Jan 2024 Common Stock 628K $22.29 Direct F3
holding BTSG Stock Options (Right to Buy) 26 Jan 2024 Common Stock 320K $13.00 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Options granted on October 16, 2019, of which 955,823 vested on January 25, 2024 in connection with the pricing of the Issuer's initial public offering, with the remaining options subject to a time-based vesting schedule, of which, the remaining 46,803 unvested options will fully vest on March 5, 2024. Reflects a 15.7027-for-1 forward stock split of the Issuer's common stock, which became effective on January 25, 2024 (the "Stock Split"). Does not include unvested performance-based options which will be reported when earned upon achievement of certain performance criteria.
F2 These options are fully vested. Reflects the Stock Split.
F3 Options granted on November 22, 2023 which vest one-third on May 22, 2024, and the remaining two-thirds to vest in equal monthly installments over the two years subsequent to the grant date. Reflects the Stock Split.
F4 Options granted on January 25, 2024 which vest in twelve equal quarterly installments commencing on April 25, 2024.

Remarks:

Title: Chairman, President and Chief Executive Officer. The Reporting Person states that this filing shall not be an admission that the Reporting Person is the beneficial owner of any of the securities reported herein as indirectly owned, and the Reporting Person disclaims beneficial ownership of such securities except to the extent of the Reporting Person's pecuniary interest therein. Exhibit List: Exhibit 24 - Power of Attorney.